Reference List

References to papers published in scientific journals mentioned in this website are given below, where possible with the full paper if you would like to read more about it. In some cases, you will find that only a summary of the paper (the 'abstract') is available. This is because the publishers of the journals make a charge to download the full article.

All links open in a new browser window.

ABN 2009. Association of British Neurologists. ABN guidelines for treatment of multiple sclerosis with beta interferon and glatirmer acetate. (www.theabn.org/abn/userfiles/file/ABN_MS_Guidelines_2009_Final.pdf)

CCOHTA 1998. Otten N. Comparison of Drug treatments for Multiple Sclerosis. Ottawa: Canadian Co-ordinating Office for Health Technology Assessment (CCOHTA) 1998 (www.ccohta.ca/publications/pdf/ms_tech_e.pdf)

Cochrane Gray 2004. Gray O, McDonnell GV, Forbes RB. Methotrexate for multiple sclerosis (Cochrane Review). The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd. ( www.update-software.com/abstracts/ab003208.htm)

Cochrane Munari 2004. Munari L, Lovati R, Boiko A. Therapy with glatiramer acetate for multiple sclerosis (Cochrane Review). The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd. ( www.update-software.com/abstracts/ab004678.htm)

Cochrane Rice 2004. Rice G PA, Incorvaia B, Munari L, Ebers G, Polman C, D'Amico R, Filippini G. Interferon in relapsing-remitting multiple sclerosis (Cochrane Review). The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd. (www.update-software.com/abstracts/ab002002.htm)

Durelli 2006. Durelli L, Barbero P, Clerico M; INCOMIN Trial Study Group. A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis. Neurology. 2006 Dec 26;67(12):2264 (abstract not available online)

Edgar 2004. Edgar CM, Brunet DG, Fenton P, McBride EV, Green P. Lipoatrophy in patients with multiple sclerosis on glatiramer acetate. Can J Neurol Sci. 2004
Feb;31(1):58-63. (www.cjns.org/31febtoc/lipoatrophy.html)

European Medicines Agency 2010. European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri. Press release. (www.ema.europa.eu/humandocs/PDFs/EPAR/tysabri/3760710en.pdf)

Francis 2003. Francis GS, Grumser Y, Alteri E, Micaleff A, O'Brien F, Alsop J, Stam Moraga
M, Kaplowitz N. Hepatic reactions during treatment of multiple sclerosis with
interferon-beta-1a: incidence and clinical significance. Drug Saf. 2003;26(11):815-27. (www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed& dopt=Abstract&list_uids=12908850)

Goodkin 1995. Goodkin DE, Rudick RA, VanderBrug Medendorp S, Daughtry MM, Schwetz KM, Fischer J, Van Dyke C. Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol. 1995 Jan;37(1):30-40. (www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=7818255)

Risk Sharing Scheme leaflet. (www.mstrust.org.uk/downloads/rss.pdf)

Kurtzke 1983. (EDRS) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Kurtzke JF. Neurology. 1983 Nov;33(11):1444-52. (www.neurology.org/cgi/content/abstract/33/11/1444)

Mancardi 2000. Mancardi GL, Murialdo A, Drago F, Brusati C, Croce R, Inglese M, Ratto S. Localized lipoatrophy after prolonged treatment with copolymer 1. J Neurol. 2000 Mar;247(3):220-1.
(abstract not available online)

NICE 2002. National Institute for Clinical Excellence. Interferon beta and glatiramer acetate for the treatment of multiple sclerosis. Technology Appraisal Guidance - No.32. London 2002 (www.nice.org.uk/cat.asp?c=27588)

NICE 2003. National Institute for Clinical Excellence. Management of multiple sclerosis in primary and secondary care. Clinical Guideline No. CG8. London 2003 (www.nice.org.uk/Guidance/CG8/PublicInfo/pdf/English)

NICE 2007. National Institute for Clinical Excellence. Natalizumab for the treatment of adults with highly active relapsing-remitting multiple sclerosis. Technology Appraisal Guidance - No. 127. London 2007 (www.nice.org.uk/Guidance/TA127)

Palace 1997. Palace J, Rothwell P. New treatments and azathioprine in multiple sclerosis. Lancet 1997 Jul 26;350(9073):261.
(abstract not available online)

Panitch 2005. Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial. J Neurol Sci. 2005 Dec 15;239(1):67-74 (www.ncbi.nlm.nih.gov/pubmed/16169561?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum)

Polman 2006. Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006 Mar 2;354(9):899-910. (www.ncbi.nlm.nih.gov/pubmed/16510744?ordinalpos=14&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum)

Rudick 2006. Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue EW, Lublin FD, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med. 2006 Mar 2;354(9):911-23. (www.ncbi.nlm.nih.gov/pubmed/16510745?ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum)

Scottish Medicines Consortium 2006. Assessment of natalizumab (Tysabri) in the treatment of MS (no. 329/06) (www.scottishmedicines.org.uk/smc/files/natalizumab%20300mg%20concentrate%20for%20solution%20for%20infusion%20(Tysabri)%20Resubmission%20FINAL%20August%202007%20for%20website.pdf)

Yudkin 1991. Yudkin PL, Ellison GW, Ghezzi A, Goodkin DE, Hughes RA, McPherson K, Mertin J, Milanese C. Overview of azathioprine treatment in multiple sclerosis. Lancet. 1991 Oct 26;338(8774):1051-5. (www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=1681364)